Found: 12
Select item for more details and to access through your institution.
Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It.
- Published in:
- Cells (2073-4409), 2019, v. 8, n. 12, p. 1506, doi. 10.3390/cells8121506
- By:
- Publication type:
- Article
LOXL2—A New Target in Antifibrogenic Therapy?
- Published in:
- International Journal of Molecular Sciences, 2019, v. 20, n. 7, p. 1634, doi. 10.3390/ijms20071634
- By:
- Publication type:
- Article
Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease.
- Published in:
- International Journal of Molecular Sciences, 2016, v. 17, n. 11, p. 1878, doi. 10.3390/ijms17111878
- By:
- Publication type:
- Article
Update on epidemiology of hepatitis B in a low‐endemic European country: There is still much to do.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 11, p. 1261, doi. 10.1111/jvh.13350
- By:
- Publication type:
- Article
Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain.
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 4, p. 360, doi. 10.1111/jvh.13238
- By:
- Publication type:
- Article
Effectiveness and safety of elbasvir/grazoprevir therapy in patients with chronic HCV infection: Results from the Spanish HEPA‐C real‐world cohort.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 1, p. 55, doi. 10.1111/jvh.13008
- By:
- Publication type:
- Article
Real‐life effectiveness of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients previously treated with sofosbuvir/velpatasvir or glecaprevir/pibrentasvir.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 2, p. 201, doi. 10.1111/apt.18020
- By:
- Publication type:
- Article
Hepatitis C Micro-Elimination beyond Prison Walls: Navigator-Assisted Test-and-Treat Strategy for Subjects Serving Non-Custodial Sentences.
- Published in:
- Diagnostics (2075-4418), 2021, v. 11, n. 5, p. 877, doi. 10.3390/diagnostics11050877
- By:
- Publication type:
- Article
NS5A Resistance: Clinical Implications and Treatment Possibilities.
- Published in:
- AIDS Reviews, 2016, v. 18, n. 1, p. 15
- By:
- Publication type:
- Article
Rescue Therapy for Genotype-3 DAA Non-responders, Almost all Done
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2019, v. 18, n. 1, p. 236, doi. 10.5604/01.3001.0012.7931
- By:
- Publication type:
- Article
Changes in Circulating Lysyl Oxidase-Like-2 (LOXL2) Levels, HOMA, and Fibrosis after Sustained Virological Response by Direct Antiviral Therapy.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 8, p. 1242, doi. 10.3390/jcm8081242
- By:
- Publication type:
- Article
Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFNγ and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells.
- Published in:
- Viruses (1999-4915), 2021, v. 13, n. 4, p. 635, doi. 10.3390/v13040635
- By:
- Publication type:
- Article